Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

EELS (Ethical, Economic, Legal & Social) Article

Ethical, social and legal issues in pharmacogenomics

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. New York Times, July 28, 2001, B1.

  2. Roses AD . Genetically validated targets for discovery, pharmacogenetics for development. HGM 2000, Human Genome Meeting Programme and Abstract Book, abstract 24, p. XXXV.

  3. Motulsky AG . If I had a gene test, what would I have and who could I tell? Lancet 1999; 354 (Suppl. I): 3537.

    Google Scholar 

  4. Geer KP, Ropka ME, Cohn WF, Jones SM, Miesfeldt S . Factors influencing patients' decisions to decline cancer genetic counseling services. J Genet Counsel 2001; 10: 25–40.

    Article  CAS  Google Scholar 

  5. American Medical Association Council on Ethical and Judicial Affairs Testing Children for Genetic Status. Code of Medical Ethics, Report 66. AMA: Chicago, 1995.

  6. American Society of Human Genetics Board of Directors and American College of Medical Genetics Board of Directors. Points to consider: ethical, legal and psychosocial implications of genetic testing in children and adolescents. Am J Genet 1995; 57: 1233–1236.

  7. Clinical Genetics Society (UK). Report of a working party of the Clinical Genetics Society. In: Clarke A (ed). The genetic testing of children. Bios Scientific: Oxford, 1998, pp 281–328.

  8. Rai AK . Prescription drug liability: the impact of pharmacogenomics. Health Law News 2001; XIV: 8, 14.

    Google Scholar 

  9. Moore v . Regents of the University of California793 P.2d 479 (Cal. 1990).

  10. Knoppers BM, Chadwick R, Takebe H, Berg K, Cantu JM, Daar AS et al. HUGO urges genetic benefit-sharing. Community Genet 2000; 3: 88–92.

    Google Scholar 

  11. Bentham J . An Introduction to the Principles of Morals and Legislation. Hafner: New York, 1948 [1789].

    Google Scholar 

  12. Singer P . Animal Liberation, 2nd edn. New York Review of Books/Random House: New York, 1990.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

DUALITY OF INTEREST

None declared.

Dr. Wertz tragically died on 29 April, 2003 in Cancun, Mexico. She is deeply missed by fellow members of the HUGO Ethics Committee, and her friends and colleagues around the world. This article is dedicated to her memory. Her academic address was: DC Wertz, Shriver Division, University of Massachusetts Medical School, 200 Trapelo Road, Waltham, MA 02452, USA.

Correspondence should be sent to

D Macer, Institute of Biological Sciences, University of Tsukuba, Tsukuba Science City 305-8572, Japan. Tel: +81 29 853 4662; Fax: +81 29 853 6614; E-mail: macer@biol.tsukuba.ac.jp

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wertz, D. Ethical, social and legal issues in pharmacogenomics. Pharmacogenomics J 3, 194–196 (2003). https://doi.org/10.1038/sj.tpj.6500188

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500188

This article is cited by

Search

Quick links